Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris

Phototherapy and apremilast (oral phosphodiesterase‐4 inhibitor) are well‐known in the treatment of moderate to severe psoriasis vulgaris. However, current evidence on the efficacy and safety of their combination is not sufficient. This multicenter, randomized controlled study compared the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Akimichi, Yamaguchi, Yukie, Tateishi, Chiharu, Ikumi, Kyoko, Yamamoto, Aya, Nishihara, Haruna, Hayashi, Daisuke, Watanabe, Yukihiko, Watanabe, Yuko, Maruyama, Ayano, Masuda, Koji, Tsuruta, Daisuke, Katoh, Norito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087908/
https://www.ncbi.nlm.nih.gov/pubmed/36151864
http://dx.doi.org/10.1111/1346-8138.16566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087908/
https://www.ncbi.nlm.nih.gov/pubmed/36151864
http://dx.doi.org/10.1111/1346-8138.16566

Ejemplares similares